Skip to main content

Find Clinical Trials

Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,958 public trials 2,018 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)

NCT00001869

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +29 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Completed

Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma

NCT00001270

Conditions: Breast Diseases, Breast Neoplasms, Endocrine Gland Neoplasms, +25 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Pegfilgrastim PBPC Mobilization Study

NCT00066092

Conditions: Hematology, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: Not specified

View Trial Details

Completed

VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma

NCT00085696

Conditions: B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations: UCLA School of Medicine Los Angeles, California, United States

Florida Cancer Specialists Fort Myers, Florida, United States

Emory University Cancer Institute, Winship Cancer Institute Atlanta, Georgia, United States

Georgia Cancer Specialists Marietta, Georgia, United States

View all 13 locations

View Trial Details

Completed

Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability

NCT00257114

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Sinai Hospital of Baltimore Baltimore, Maryland, United States

View Trial Details

Completed

VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

NCT00063713

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University of Alabama Birmingham, Alabama, United States

Alta Bates Medical Center Berkeley, California, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

Loma Linda Cancer Research Institute Loma Linda, California, United States

View all 35 locations

View Trial Details

Completed

Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00090090

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +18 more
Locations: Alta Bates Cancer Center Berkeley, California, United States

Providence Saint Joseph Medical Center Burbank, California, United States

USC Norris Cancer Center Los Angeles, California, United States

Tower Hematology Oncology Medical Group Los Angeles, California, United States

View Trial Details

Completed

Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)

NCT00044902

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Not specified

View Trial Details

Completed

Effectivity and Efficiency of Turning Frequencies: a Randomised Controlled Trial

NCT00262444

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University Hospital Ghent Ghent, Belgium

View Trial Details

Completed

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

NCT00146211

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +23 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic Arizona Scottsdale, Arizona, United States

University of California San Diego La Jolla, California, United States

UCLA Medical Center Los Angeles, California, United States

View all 41 locations

View Trial Details